San Diego-based Viking Therapeutics marked itself as a serious competitor within the weight loss drug market place in February following revealing promising info from a mid-phase demo of experimental drug VK2735, which recommended it rivaled—and outperformed—Novo and Lilly drugs when provided being a weekly injection As well as in March the com